Close Menu

NEW YORK (GenomeWeb) – Biodesix has signed an agreement making Mumbai-based Positive Bioscience a distributor of its liquid biopsy tests for non-small cell lung cancer in India, the companies announced today.

Under the terms of the deal, Positive will offer Biodesix's GeneStrat and VeriStrat in India. All testing will be performed at Biodesix's laboratory in Boulder, Colorado. Additional terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

May
22

This webinar will outline the entire liquid biopsy workflow from cell-free DNA isolation to mutation detection by Crystal Digital PCR with the Naica System from Stilla Technologies.

Jun
13

Ribosomal ribonucleic acid (rRNA) accounts for up to 99 percent of the total RNA depending on the cell type. 

Jun
18
Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect. 

Jun
19

This webinar will discuss cell-free DNA prenatal screening in the era of genome-wide sequencing and factors influencing the clinical utility of expanded noninvasive prenatal testing (NIPT) menus.